Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Two Markman Victories..does .14 cents per share seem even remotely appropriate?

I agree with you and wholeheartedly question why we are at such low levels. But then the voice on my shoulder whispers, "if it is so absurdly low as you think, why then does the CFO, acting CEO refuse to buy stock claiming it is too risky for him". Perhaps that is a dose of reality that I don't like hearing but Cliff is our leader and leaders lead by example.

Share
New Message
Please login to post a reply